Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00100295 · ClinicalTrials.gov registry record · Phase 2
Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 59
- Enrollment target
NCT00100295 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 59 participants.
The verdict
NCT00100295, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of an herbal product for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Interventions
- OTHER Placebo
- DRUG Hypericum perforatum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2005-02 |
| Est. Completion | 2006-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00100295
The ClinicalTrials.gov registry entry for NCT00100295 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00100295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00100295 about?
NCT00100295 is a clinical study titled "Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)". The purpose of this study is to determine the safety and effectiveness of an herbal product for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents.
What is the current status of trial NCT00100295?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 59 participants. The study started on 2005-02. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00100295?
The interventions under investigation include: Placebo (OTHER), Hypericum perforatum (DRUG).
Who is sponsoring clinical trial NCT00100295?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.